ASCO Updates Breast Cancer Follow
The American Society of Clinical Oncology (ASCO) has updated its guidelines for breast cancer follow-up, moving toward a risk-stratified approach. This new framework aims to tailor surveillance intensity based on individual patient risk rather than a one-size-fits-all model.
Why it matters
This shift addresses the need for more efficient healthcare resource allocation while acknowledging the current lack of high-quality evidence for uniform surveillance.
The American Society of Clinical Oncology has released an updated guideline on breast cancer follow-up and surveillance after primary treatment, introducing a more risk-adapted approach to post-treatment care for patients who have completed curative-intent therapy and have no clinical evidence of disease.
The article provides a straightforward summary of medical guidelines and expert panel findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in